Nutraceuticals comprise foods, or extracts from foods, that supposedly confer medicinal benefits. Nutraceuticals have become popular with the veterinary community; worldwide estimates of sales approach $100 billion. Such economic success has, for the most part, not been accompanied by scientific evidence of efficacy. As with herbs, a broad and continually expanding spectrum of nutraceuticals exists, but the mechanisms of action, indications, contraindications, adverse effects, and evidential support vary with the product and species. It is beyond the scope of this brief summary to discuss specific nutraceutical products.

One type of nutraceutical in particular warrants mention. “Glandulars,” “tissue extracts,” or other scientific-sounding equivalent names purportedly improve the health of animals whose same glands or tissues have become dysfunctional. Despite the fact that these products are not FDA approved for veterinary usage, veterinary glandulars and related supplements are heavily promoted in the lay veterinary medicine literature. Their usage began in the USA during the late 19th century when the practice arose of giving fresh thyroid glands to patients as treatment for hypothyroidism. Subsequently, tissues and extracts from other organs (ovary, adrenal, testis, thymus, brain, etc) became popular treatments. Once standardized medications and hormonal replacements became available, medical practitioners largely ceased prescribing glandular derivatives because medication offered more reliable effects without the unpredictable hormonal effects of extracts and concentrates. The use of raw bovine pancreas in some dogs with exocrine pancreatic insufficiency is a notable exception. Of specific concern is the potential for brain and spinal cord derivatives to act as a source of infection for transmissible spongiform encephalopathies.

Last full review/revision July 2011 by Narda G. Robinson, DO, DVM, MS, FAAMA